Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors

NCT05985941 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05985941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05985941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2023
Completion date
May 31, 2028
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multi-omics analysis, rare gynecological tumors